Announcements Trials
Browse Landscape

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 8INDUSTRY 3NETWORK 1

Study Type

Interventional 99Observational 3Expanded_access 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Observational × pertuzumab × Clear all
NCT04158258 2026-04-23

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Hoffmann-La Roche

Active not recruiting
2,907 enrolled
Breast

Breast Neoplasms

NCT02266173 2021-05-03

Observational Study of Pertuzumab Safety in Participants With Breast Cancer

Hoffmann-La Roche

Completed
1,130 enrolled
Breast

Breast Neoplasms

NCT00833963 2019-05-16

MotHER

Genentech, Inc.

Completed
20 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡